Literature DB >> 25785142

Prevalence and fluoroquinolone resistance of pseudomonas aeruginosa in a hospital of South China.

Xiaoyan Yang1, Bangrong Xing1, Caiqian Liang1, Zhuopeng Ye2, Yongbiao Zhang1.   

Abstract

Pseudomonas aeruginosa is an opportunistic pathogen that poses a threat in clinical settings. This study aimed to investigate the molecular characterization and epidemiology of fluoroquinolones (FQs) resistance in P. aeruginosa isolated from South China. A total of 256 P. aeruginosa strains isolated from outpatients, emergency patients and inpatients were collected from January 2010 to December 2010 in the hospital of South China. The resistance profile of all isolated strains was screened by antibiotic-susceptibility testing, and the molecular characteristics of plasmid-mediated quinolone resistance (PMQR) and the quinolone resistance determining region (QRDR) were determined using PCR in combination with DNA sequencing. The result of antibiotic-susceptibility tests showed that most strains were sensitive to polymyxin B, piperacillin, piperacillin/tazobactam, ceftazidime and amikacin. Moreover, 65 isolates were identified as resistant to ciprofloxacin. Further analysis of QRDR revealed that the resistant strains carried at least one mutation in the gyrA (The83Ile), gyrB (Ser467Phe, Gln468His) and parC (Ser87Leu) genes, but no mutation was detected in parE. For the first time, we report here that the qnrA1 gene is associated with low levels of resistance to ciprofloxacin from clinical P. aeruginosa isolates in South China. The mutation of gyrA (at position 83) is clearly linked to the FQs resistance of P. aeruginosa. Moreover, FQs resistance of P. aeruginosa may be due to the chromosome-mediated resistance mechanism rather than PMQR.

Entities:  

Keywords:  Fluoroquinolone resistance; PMQR; Pseudomonas aeruginosa; QRDR

Year:  2015        PMID: 25785142      PMCID: PMC4358597     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  14 in total

1.  National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2003, issued August 2003.

Authors: 
Journal:  Am J Infect Control       Date:  2003-12       Impact factor: 2.918

Review 2.  Mobile gene cassettes and integrons: moving antibiotic resistance genes in gram-negative bacteria.

Authors:  R M Hall
Journal:  Ciba Found Symp       Date:  1997

Review 3.  Consensus review of the epidemiology and appropriate antimicrobial therapy of complicated urinary tract infections in Asia-Pacific region.

Authors:  Po-Ren Hsueh; Daryl J Hoban; Yehuda Carmeli; Shey-Ying Chen; Sunita Desikan; Marissa Alejandria; Wen-Chien Ko; Tran Quang Binh
Journal:  J Infect       Date:  2011-06-12       Impact factor: 6.072

4.  Tap water colonization with Pseudomonas aeruginosa in a surgical intensive care unit (ICU) and relation to Pseudomonas infections of ICU patients.

Authors:  M Trautmann; T Michalsky; H Wiedeck; V Radosavljevic; M Ruhnke
Journal:  Infect Control Hosp Epidemiol       Date:  2001-01       Impact factor: 3.254

5.  Fluoroquinolone prescribing in the United States: 1995 to 2002.

Authors:  Jeffrey A Linder; Elbert S Huang; Michael A Steinman; Ralph Gonzales; Randall S Stafford
Journal:  Am J Med       Date:  2005-03       Impact factor: 4.965

6.  Identification of PER-1 extended-spectrum beta-lactamase producing Pseudomonas aeruginosa clinical isolates of the international clonal complex CC11 from Hungary and Serbia.

Authors:  Balázs Libisch; Laurent Poirel; Zorica Lepsanovic; Veljko Mirovic; Boglárka Balogh; Judit Pászti; Zsuzsanna Hunyadi; András Dobák; Miklós Füzi; Patrice Nordmann
Journal:  FEMS Immunol Med Microbiol       Date:  2008-12

7.  Pseudomonas aeruginosa in a neonatal intensive care unit: reservoirs and ecology of the nosocomial pathogen.

Authors:  H Grundmann; A Kropec; D Hartung; R Berner; F Daschner
Journal:  J Infect Dis       Date:  1993-10       Impact factor: 5.226

8.  Fluoroquinolone resistance of Pseudomonas aeruginosa isolates causing nosocomial infection is correlated with levofloxacin but not ciprofloxacin use.

Authors:  Yuarn-Jang Lee; Hsin-Yi Liu; Yi-Chun Lin; Kuo-Lun Sun; Chi-Li Chun; Po-Ren Hsueh
Journal:  Int J Antimicrob Agents       Date:  2009-12-31       Impact factor: 5.283

9.  Prevalence of plasmid-mediated quinolone resistance determinants over a 9-year period.

Authors:  Hong Bin Kim; Chi Hye Park; Chung Jong Kim; Eui-Chong Kim; George A Jacoby; David C Hooper
Journal:  Antimicrob Agents Chemother       Date:  2008-12-08       Impact factor: 5.191

10.  qnrD, a novel gene conferring transferable quinolone resistance in Salmonella enterica serovar Kentucky and Bovismorbificans strains of human origin.

Authors:  L M Cavaco; H Hasman; S Xia; F M Aarestrup
Journal:  Antimicrob Agents Chemother       Date:  2008-11-24       Impact factor: 5.191

View more
  17 in total

Review 1.  SOS response and its regulation on the fluoroquinolone resistance.

Authors:  Ting-Ting Qin; Hai-Quan Kang; Ping Ma; Peng-Peng Li; Lin-Yan Huang; Bing Gu
Journal:  Ann Transl Med       Date:  2015-12

2.  A large-scale whole-genome comparison shows that experimental evolution in response to antibiotics predicts changes in naturally evolved clinical Pseudomonas aeruginosa.

Authors:  Samuel J T Wardell; Attika Rehman; Lois W Martin; Craig Winstanley; Wayne M Patrick; Iain L Lamont
Journal:  Antimicrob Agents Chemother       Date:  2019-09-30       Impact factor: 5.191

Review 3.  Plasmid-mediated quinolone resistance in Enterobacteriaceae: a systematic review with a focus on Mediterranean countries.

Authors:  B Yanat; J-M Rodríguez-Martínez; A Touati
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-11-26       Impact factor: 3.267

4.  Prevalence of qnrVC Genes in Pseudomonas aeruginosa Clinical Isolates from Guangdong, China.

Authors:  Jinqiong Lin; Ding-Qiang Chen; Jianming Hong; Huanhuan Huang; Xia Xu
Journal:  Curr Microbiol       Date:  2020-04-03       Impact factor: 2.188

5.  Gene-Gene Interactions Dictate Ciprofloxacin Resistance in Pseudomonas aeruginosa and Facilitate Prediction of Resistance Phenotype from Genome Sequence Data.

Authors:  Attika Rehman; Julie Jeukens; Roger C Levesque; Iain L Lamont
Journal:  Antimicrob Agents Chemother       Date:  2021-06-17       Impact factor: 5.191

Review 6.  Double-Serine Fluoroquinolone Resistance Mutations Advance Major International Clones and Lineages of Various Multi-Drug Resistant Bacteria.

Authors:  Miklos Fuzi; Dora Szabo; Rita Csercsik
Journal:  Front Microbiol       Date:  2017-11-16       Impact factor: 5.640

7.  Mutations in the gyrA, parC, and mexR genes provide functional insights into the fluoroquinolone-resistant Pseudomonas aeruginosa isolated in Vietnam.

Authors:  Kinh Van Nguyen; Trung Vu Nguyen; Hang Thi Thuy Nguyen; Duyet Van Le
Journal:  Infect Drug Resist       Date:  2018-02-28       Impact factor: 4.003

8.  Multiple mechanisms contributing to ciprofloxacin resistance among Gram negative bacteria causing infections to cancer patients.

Authors:  Samira M Hamed; Walid F Elkhatib; Hadir A El-Mahallawy; Mai M Helmy; Mohamed S Ashour; Khaled M A Aboshanab
Journal:  Sci Rep       Date:  2018-08-16       Impact factor: 4.379

9.  Clinical and Molecular Epidemiology of Multidrug-Resistant P. aeruginosa Carrying aac(6')-Ib-cr, qnrS1 and blaSPM Genes in Brazil.

Authors:  Bruna Fuga Araujo; Melina Lorraine Ferreira; Paola Amaral de Campos; Sabrina Royer; Deivid William da Fonseca Batistão; Raquel Cristina Cavalcanti Dantas; Iara Rossi Gonçalves; Ana Luiza Souza Faria; Cristiane Silveira de Brito; Jonny Yokosawa; Paulo Pinto Gontijo-Filho; Rosineide Marques Ribas
Journal:  PLoS One       Date:  2016-05-24       Impact factor: 3.240

10.  Mutations in gyrB play an important role in ciprofloxacin-resistant Pseudomonas aeruginosa.

Authors:  Xinyuan Feng; Zhiqi Zhang; Xiaoxia Li; Yan Song; Jianbang Kang; Donghong Yin; Yating Gao; Nan Shi; Jinju Duan
Journal:  Infect Drug Resist       Date:  2019-02-08       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.